- Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution. It is controlled by the Ministry of Health and Family Welfare, Government of India.
- Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region.
- It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).
- It further promotes rational use of generic medicines by publishing National Formulary of India.
- The Indian Pharmacopoeia Commission came into existence in 2009 with a mandate to periodically publish and update Indian Pharmacopoeia.
- The Indian Pharmacopoeia Commission has so far published 1977 monographs for different therapeutic categories of drugs and vaccines.
- The Indian Pharmacopoeia Laboratory became NABL accredited for Biological and Chemicals.
- The Commission had started analyzing and validating the drug samples received at the Air Port. The Commission had analyzed and validated 206 new drugs.
- The IP Commission has prepared, certified and distributed 253 IPRS (Indian Pharmacopoeia Reference Substances) paving the way to save invaluable foreign exchange.
- Guidance manual for Compliance of Indian Pharmacopoeia (IP) was released by IPC on 12th December, 2012.
- The Pharmacovigilance Programme of India (PvPI) was launched on 14-Jul-10. Three hundred medical colleges across the country will be involved in the programme.
- The basic purpose of the programme is to collect Adverse Drug Reactions (ADRs) to commonly prescribed medicines in India. Approximately 45, 000 ADRs have so far been collected, collated and communicated to WHO – UMC (Uppsala Monitoring Centre), Sweden.
- Haemovigilance has been launched on 10th December, 2012 under Pharmacovigilance Programme of India.